ArticleRSC advances2026
Deep learning-assisted SERS for detection of propoxate and isopropoxate in E-cigarettes.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The illicit use of new psychoactive substances in e-cigarettes has posed severe threats to human health and social security, urgently necessitating the development of targeted rapid and highly sensitive detection methods. In this study, we developed a highly sensitive detection approach for propoxate and isopropoxate, commonly illegally added drugs in e-cigarettes, by integrating deep learning-assisted SERS technology. First, the characteristic spectral peaks of the two isomeric compounds were identified through conventional Raman and SERS analysis of reference standards. Furthermore, DFT calculations were employed to interpret the vibrational modes in the Raman spectra corresponding to their molecular structures. Subsequently, a sample pre-treatment method was developed for spiked e-cigarette samples, enabling trace-level SERS detection of both substances. Finally, an innovative dual-branch deep learning network integrating time-domain and frequency-domain features was developed for high-precision classification and identification of two structurally similar substances, achieving an identification accuracy of 99.73%. This study provides a reference for the detection of structurally similar compounds.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.